This activity is expired and is no longer available for CME credit.


Can Ranibizumab Resolve PEDs in AMD Patients?

Author(s)/Faculty: Anne E. Fung, MD
Release Date: 5/25/2012Expiration Date: 5/24/2015
Credit Type: CME / ParticipationNumber of Credits: 0
Content Type: Provider:
Nearly all subjects with wet AMD and fibrovascular PED refractory to at least 6 months of previous standard therapy required monthly 2mg ranibizumab injections as guided by SD-OCT. Mean visual acuity improved by 4.5 letters at 6 months, and 8 letters by 12 months. Continued monthly injections were required but did result in improved vision...